Crist, Rachael M.

Conformation of the HIV-1 Gag Protein in Solution

Datta, S. A. K., Curtis, J. E., Ratcliff, W., Clark, P. K., Crist, R. M., Lebowitz, J., Krueger, S., & Rein, A. (2007) · Journal of Molecular Biology

HIV Research and TreatmentProtein Structure and Dynamics

Cited by 145

On the Role of the SP1 Domain in HIV-1 Particle Assembly: a Molecular Switch?

Datta, S. A. K., Temeselew, L. G., Crist, R. M., Soheilian, F., Kamata, A., Mirro, J., Harvin, D., Nagashima, K., Cachau, R. E., & Rein, A. (2011) · Journal of Virology

HIV Research and TreatmentProtein Structure and Dynamics

Cited by 127

The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery

Kularatne, R. N., Crist, R. M., & Stern, S. T. (2022) · Pharmaceuticals

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 109

Report of the AAPS Guidance Forum on the FDA draft guidance for industry:“drug products, including biological products, that contain nanomaterials”

de Vlieger, J. S. B., Crommelin, D. J. A., Tyner, K., Drummond, D. C., Jiang, W., McNeil, S. E., Neervannan, S., Crist, R. M., & Shah, V. P. (2019) · The AAPS Journal

Nanoparticle-Based Drug DeliveryPharmaceutical studies and practices

Cited by 100

The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines

Hu, Y., Crist, R. M., & Clogston, J. D. (2020) · Analytical and Bioanalytical Chemistry

Field-Flow Fractionation TechniquesNanoparticle-Based Drug Delivery

Cited by 49

Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay

Skoczen, S. L., Snapp, K. S., Crist, R. M., Kozak, D., Jiang, X., Liu, H., & Stern, S. T. (2020) · ACS Pharmacology & Translational Science

Nanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

Cited by 31